Olumiant (baricitinib) Patient Assistance Program
Don’t let the high cost of brand specialty JAK inhibitor therapy disrupt your treatment. We help eligible patients access Olumiant (baricitinib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Olumiant (baricitinib) is FDA-approved for moderately to severely active rheumatoid arthritis (RA) in adults with inadequate response to one or more TNF blockers, severe alopecia areata in adults, and COVID-19 in certain hospitalized adults requiring supplemental oxygen.
- Without assistance, Olumiant costs commonly run approximately $4,800–$5,400 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Olumiant for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process
- There is no generic Olumiant in the U.S. as of 2026. Other JAK inhibitors include tofacitinib (Xeljanz, generic available 2025), upadacitinib (Rinvoq), abrocitinib (Cibinqo). For RA, biologic alternatives include TNF blockers (with biosimilar generics for adalimumab/Humira and infliximab/Remicade) and other mechanisms.
What Is Olumiant Prescription Assistance Program?
The Olumiant Prescription Assistance Program is a manufacturer-sponsored initiative that provides Olumiant at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for RA, alopecia areata, and other approved indications in patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, rheumatology/dermatology coordination, REMS compliance, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, Olumiant costs roughly $4,800–$5,400/month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$5,300 | Save ~$5,230/mo |
| CVS Pharmacy | ~$5,400 | Save ~$5,330/mo |
| Walmart | ~$4,900 | Save ~$4,830/mo |
| Costco | ~$4,850 | Save ~$4,780/mo |
| Specialty Pharmacy | ~$5,000 | Save ~$4,930/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Olumiant Prescription Program?
The Patient Assistance Program is free to apply for and provides Olumiant at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Olumiant:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $4,800–$5,400 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Olumiant assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Olumiant Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Olumiant:
Olumiant (baricitinib) is a once-daily oral selective inhibitor of Janus kinase 1 and 2 (JAK1/JAK2) used for moderately to severely active RA, severe alopecia areata, and COVID-19 in select hospitalized patients.
How Olumiant Works:
Baricitinib selectively inhibits JAK1 and JAK2, which are intracellular kinases that activate inflammatory gene expression. By disrupting these signaling pathways, the drug reduces inflammation driven by cytokines in the joints, hair follicles, and lungs. This makes it an effective treatment for rheumatoid arthritis, alopecia areata, and the cytokine storms associated with COVID-19.
Form and use:
Olumiant is an oral tablet taken once daily, with or without food, available in 1 mg, 2 mg, and 4 mg strengths. While the 2 mg dose is standard for rheumatoid arthritis and alopecia, the 4 mg dose is specifically approved for severe alopecia areata. Dosages may require adjustments based on a patient’s renal function or the use of certain inhibitors like probenecid.
Generic availability:
As of 2026, there is no generic version of Olumiant available in the United States. While other JAK inhibitors like tofacitinib have generics, baricitinib remains a brand-name product alongside competitors like Rinvoq and Litfulo. Patients seeking lower-cost alternatives for rheumatoid arthritis often look toward biosimilars for injectable drugs like Humira or Remicade.
Warnings:
This medication carries boxed warnings for serious infections, increased mortality, malignancies, and major cardiovascular events or thrombosis. Users must undergo screening for tuberculosis and viral hepatitis before starting treatment due to the risk of reactivating infections. Additionally, it may cause laboratory abnormalities such as lipid changes and neutropenia, and it is associated with risks of gastrointestinal perforation and embryo-fetal toxicity.
FAQ (Frequently Asked Questions)
How Much Does Olumiant Cost Without Insurance?
Olumiant costs approximately $4,800–$5,400 per 30-day supply. Through AffordMyPrescriptions, qualifying patients receive Olumiant at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
What Is A JAK Inhibitor?
JAK inhibitors are oral medications that block Janus kinase enzymes inside cells, disrupting signaling from many cytokines that drive autoimmune disease and certain inflammatory conditions. Olumiant (baricitinib) blocks JAK1 and JAK2. Other JAK inhibitors block different combinations (tofacitinib targets JAK1/JAK3, upadacitinib targets JAK1, abrocitinib targets JAK1, ritlecitinib targets JAK3/TEC). The clinical profile of each JAK inhibitor depends partly on its selectivity.
Is Olumiant The Same As Xeljanz Or Rinvoq?
All three are JAK inhibitors used in some of the same conditions. Their selectivity differs (baricitinib: JAK1/2; tofacitinib: JAK1/3; upadacitinib: JAK1). Their FDA-approved indications differ — Olumiant is approved for RA, alopecia areata, and certain COVID-19 patients; Xeljanz is approved for RA, PsA, UC, JIA, and ankylosing spondylitis; Rinvoq is approved for RA, PsA, atopic dermatitis, ankylosing spondylitis, axial SpA, ulcerative colitis, and Crohn’s disease. They share the JAK-class boxed warnings.
Why Does Olumiant Have So Many Boxed Warnings?
JAK inhibitors as a class carry boxed warnings for serious infections, increased mortality (in older RA patients with cardiovascular risk factors based on tofacitinib study data), malignancies, major adverse cardiovascular events, and thrombosis. The warnings reflect the broad effects of blocking JAK signaling on the immune system and other tissues. Risk-benefit should be discussed carefully with your provider — these medications can be very effective when other therapies have failed.
Do I Need TB Or Hepatitis Testing Before Starting?
Yes. Latent tuberculosis testing (PPD or QuantiFERON) and hepatitis B/C screening are required before starting Olumiant. JAK inhibitors can reactivate latent TB and hepatitis B.
Can I Get Olumiant Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If denied, we explore alternatives — switching to a different JAK inhibitor with its own PAP (Xeljanz with generic, Rinvoq), a TNF biosimilar (much lower cost than brand TNF blockers), or another biologic mechanism, the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Arthritis Foundation, NAAF (National Alopecia Areata Foundation), PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Olumiant, our team may be able to help you access assistance programs designed to make brand specialty JAK inhibitors affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.